Related Experiment Videos
[Fas mediated apoptosis inhibited by human bcl-2 gene in lymphoma cell line Jurkat]
1Tumor Immunology and Gene Therapy Center, Eastern Institute of Hepatobiliary Surgery, Shanghai 200433.
Objective:
To understand the mechanism of bcl-2 gene in escaping the immune surveillance in the development of lymphoma.
Methods:
A recombinant retroviral vector pLXSN-bcl-2 was constructed by cloning bcl-2 cDNA into the replication defective retroviral vector pLXSN, and transferred to packaging cell line PA317 by electroporation. The G418 resistant colonies were selected, and the supernatants of the colony cultures were used to infect the human lymphoma cell line Jurkat. Cells in G418 resistant Jurkat colonies were characterized by immunohistochemistry. Anti-Fas monoclonal antibody (McAb) was applied to Jurkat cells for inducing apoptosis which mimicked the cytotoxic activity of T lymphocyte.
Results:
Expression of bcl-2 in pLXSN-bcl-2 transfected Jurkat cell (Jurkat-bcl-2) increased, while there was no change of Fas gene expression. Apoptosis was blocked in Jurkat-bcl-2 by anti-Fas McAb treatment.
Conclusion:
Overexpression of bcl-2 in lymphoma cell line could inhibit cell apoptosis induced by anti Fas McAb, suggesting that overexpression of bcl-2 is one of the mechanisms in escaping immune surveillance in the development of lymphoma.
Insights
The BCL-2 gene helps lymphoma cells evade immune detection by blocking apoptosis, a key process in cancer development. This finding sheds light on how cancer cells survive immune responses.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- Lymphoma development involves complex mechanisms of immune evasion.
- Understanding how cancer cells escape immune surveillance is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of the BCL-2 gene in lymphoma's immune surveillance evasion.
- To elucidate the mechanism by which BCL-2 contributes to lymphoma pathogenesis.
Main Methods:
- Constructed a recombinant retroviral vector (pLXSN-bcl-2) for BCL-2 gene transfer.
- Transfected human lymphoma Jurkat cells and selected for stable expression.
- Induced apoptosis using anti-Fas monoclonal antibody to mimic T-cell cytotoxic activity.
Main Results:
- BCL-2 gene expression was significantly upregulated in transfected Jurkat cells.
- Fas gene expression remained unchanged.
- Apoptosis induction by anti-Fas antibody was inhibited in Jurkat cells overexpressing BCL-2.
Conclusions:
- Overexpression of BCL-2 inhibits Fas-mediated apoptosis in lymphoma cells.
- BCL-2 contributes to lymphoma immune evasion by preventing programmed cell death.
- Targeting BCL-2 may offer a therapeutic strategy for lymphoma.